Social engagement
Social engagement: 725 social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
3 investors on record; lead investors include Nina Capital, Debiopharm.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 33% |
| Other / undisclosed | 2 | 67% |
Recent activity
25 Jun 2026
Event
2nd Operationalize: Expanded Access Programs (OEAP) Summit West
2 Jun 2026
Event
World Orphan Drug Congress USA
21 May 2026
Event
Build vs. Buy in Expanded Access Programs